BANK OF MONTREAL /CAN/ - ANTARES PHARMA INC ownership

ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 87 filers reported holding ANTARES PHARMA INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of ANTARES PHARMA INC
ValueSharesWeighting
Q3 2021$1,033,000
-9.9%
269,558
+3.4%
0.00%
-100.0%
Q2 2021$1,147,000
+45.0%
260,699
+35.8%
0.00%0.0%
Q1 2021$791,000
-26.4%
191,943
-27.8%
0.00%0.0%
Q4 2020$1,074,000
+104.6%
265,717
+52.3%
0.00%
Q3 2020$525,000
+5.4%
174,516
-9.6%
0.00%
Q2 2020$498,000
+24800.0%
192,973
+16680.3%
0.00%
Q1 2020$2,000
-97.9%
1,150
-94.4%
0.00%
Q4 2019$96,000
+104.3%
20,426
+43.9%
0.00%
Q3 2019$47,000
+4.4%
14,190
+3.9%
0.00%
Q2 2019$45,000
+800.0%
13,660
+594.5%
0.00%
Q4 2018$5,000
+66.7%
1,967
+98.1%
0.00%
Q3 2018$3,0000.0%993
-2.8%
0.00%
Q2 2018$3,000
+200.0%
1,022
-4.0%
0.00%
Q1 2016$1,0000.0%1,0650.0%0.00%
Q4 2015$1,0000.0%1,065
+36.5%
0.00%
Q3 2014$1,000
-85.7%
780
-71.0%
0.00%
Q2 2014$7,000
-30.0%
2,690
+13.3%
0.00%
Q3 2013$10,0000.0%2,3750.0%0.00%
Q2 2013$10,0002,3750.00%
Other shareholders
ANTARES PHARMA INC shareholders Q4 2015
NameSharesValueWeighting ↓
Sargent Investment Group, LLC 3,096,355$8,422,0005.18%
JW Asset Management, LLC 1,920,524$5,224,0003.85%
Healthcare Value Capital, LLC 250,000$680,0002.64%
ARMISTICE CAPITAL, LLC 10,300,000$28,016,0002.12%
Broadfin Capital, LLC 3,444,147$9,368,0001.23%
PERKINS CAPITAL MANAGEMENT INC 409,000$1,112,0000.86%
MYCIO WEALTH PARTNERS, LLC 1,896,500$5,158,0000.48%
ESSEX INVESTMENT MANAGEMENT CO LLC 1,012,600$2,754,0000.22%
FALCON POINT CAPITAL, LLC 130,200$354,0000.21%
Brown Advisory Securities, LLC 275,000$781,0000.15%
View complete list of ANTARES PHARMA INC shareholders